UFGN wrote:Scientists are trying to develop a vaccine against Covid-19 coronavirus..... bare in mind, the common cold is a coronavirus or more specifically a shitload of different coronaviruses that change and mutate regularly.
Do we have a vaccine against the cold? No of course we don't. How valuable would such a vaccine be? It would be worth ££££££. Everyone would want it.
Soooo, we have to be realistic and say we might not get a vaccine at all. It seems more likely that the solution will be to develop better treatments so that the death rate is further reduced. We might have to just live with it..... also bare in mind that some viruses weaken in their potency over time, but that takes many years.
I'm pretty clueless about viruses but from what I've been reading i don't think a lot of what you said is true.
First of all, based on a google search, the common cold is 75% rhinoviruses. There are some coronaviruses that fall under the umbrella term but they don't represent the majority. Source: https://www.verywellhealth.com/why-ther ... old-770451
Secondly, all viruses mutate regularly but the changes in Covid-19 don't seem to be that dramatic and shouldn't pose a problem for a vaccine:
Source: https://abcnews.go.com/US/covid-19-vacc ... d=71333281It may come down to the structure and biology of this particular virus. SARS-CoV-2, the virus that causes COVID-19, is covered in tiny spikes called surface proteins. Experts say that the virus is unlikely to mutate in a meaningful way, meaning the vaccines that are being developed now are likely to work in the future.
Lastly, my impression was that scientists feel pretty confident about having an effective vaccine in 2021. Here's a company claiming they'll have an emergency vaccine by October:
Source: https://www.nytimes.com/interactive/202 ... acker.htmlA vaccine in development by the British-Swedish company AstraZeneca and the University of Oxford is based on a chimpanzee adenovirus called ChAdOx1. The vaccine is in a Phase II/III trial in England and Phase III trials in Brazil and South Africa. The project may deliver emergency vaccines by October. In June, AstraZeneca said their total manufacturing capacity stands at two billion doses.
Again, I'm pretty clueless when it comes to viruses and I might be missing something obvious but everything I've read so far points me to believe that this will all be over in early 2021